BackSILO Pharma Overview

SILO Pharma EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SILO.

Quarterly EBIT

-$1.59M
45.75% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$4.79M
2.27% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)